Association between prurigo nodularis and malignancy in middle-aged adults - 11/10/19

| Funding sources: None. |
|
| Conflicts of interest: Dr Miller has received grant support from AstraZeneca, MedImmune (a subsidiary of AstraZeneca), Pfizer, Boerhinger Ingelheim, Regeneron Pharmaceuticals, Moderna Therapeutics; is a shareholder of Noveome Biotherapeutics; and is on the scientific advisory board of Integrated Biotherapeutics, which are all unrelated to the work reported in this article. Dr Kwatra is an advisory board member for Menlo and Trevi Therapeutics. Ms Larson, Ms Tang, Dr Stander, and Dr Kang have no conflicts of interest to disclose. |
|
| Reprints not available from the authors. |
Vol 81 - N° 5
P. 1198-1201 - novembre 2019 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
